Thank you for attending
INHSU 2023 is now over (remember, you can still access on-demand sessions until mid-January ’24), thank you to all of our delegates, speakers, partners and sponsors. For INHSU 2024, we’ll be heading to Athens, Greece, from 8-11 October. We look forward to seeing you there.
The professional photos from INHSU 2023 are now available online for viewing and download. Thank you to INHSU 2023 event photographer, visual storyteller Conor Ashleigh. Can you spot yourself or your team in the albums? Share your photos online and tag @inhepSU on twitter and @INHSU_global on Instagram.
INHSU 2023 program
INHSU featured hundreds of sessions and posters on hepatitis C, infectious diseases, harm reduction, drug policy and more. View the full program and posters below and browse through the daily recaps.
- INHSU 2023 Program
- INHSU 2023 Posters
- Daily news – day one
- Daily news – day two
- Daily news – day three
- Daily news – thank you
All abstracts and posters will be added to the INHSU Conference Archive in early 2024.
Former President of the Swiss Confederation and founding member and former Chair of the Global Commission on Drug Policy
Head of Viral Hepatitis and Opioid Dependency Dept., Public Health Center of the Ministry of Health of Ukraine
Dr. Joaquin Cabezas
Gastroenterology and Hepatology Physician, Marques de Valdecilla University Hospital, Spain
Dr. Behzad Hajarizadeh
Clinical Epidemiologist and Associate Professor, the Kirby Institute, UNSW, Sydney
Dr. Marie Jauffret-Roustide
Sociologist and Research Fellow, French National Institute of Health and Medical Research
Dr. Andrew Seaman
Associate Professor of Medicine at Oregon Health & Sciences University, boarded in Internal and Addiction Medicine.
Scientia Professor Louisa Degenhardt
NHMRC Senior Principal Research Fellow and Deputy Director at the National Drug and Alcohol Research Centre (NDARC), Faculty of Medicine, UNSW, Sydney
Mr Kennedy Kipoech
PhD student at Cape Town and Bristol universities, in SA and UK, respectively